BLASOLUTIONINJECTION
Approved
Jul 2025
Lifecycle
Launch
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
5/8 — Partial
KIRSTY (water) by Biocon is insulin, including insulin aspart products, is the regulation of glucose metabolism. Approved for glycemic control in adults. First approved in 2025.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
KIRSTY is an insulin aspart analog indicated for glycemic control in adults with diabetes. It works by stimulating peripheral glucose uptake in skeletal muscle and fat while inhibiting hepatic glucose production, thereby lowering blood glucose levels. The product is administered as an injection solution.
Launch
Early-stage launch from Biocon with zero linked job openings signals a nascent commercial infrastructure; team building and market penetration efforts should scale rapidly over 12–18 months.
Mechanism of Action
insulin, including insulin aspart products, is the regulation of glucose metabolism. Insulin and its analogs lower blood glucose by stimulating peripheral glucose uptake, especially by skeletal muscle and fat, and by inhibiting hepatic glucose production. Insulin inhibits lipolysis and proteolysis,…
Pharmacologic Class:
Insulin Analog
Indications (1)
Clinical Trials (20)
Water Vapor Ablation for Prostate Cancer: Long-Term Registry
Started Apr 2026
2,500 enrolled
Prostate Cancer
Effect of Watermelon on Cardiometabolic Health
Started Apr 2026
22 enrolled
Cardiometabolic Health IndicatorsWhole-body Antioxidant Capacity
Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears
Started Dec 2025
Computer-Aided Water Exchange Colonoscopy With and Without Linked-Color Imaging for Detection of Clinically Significant Serrated Lesions
Started Nov 2025
1,090 enrolled
Sessile Colonic PolypSerrated LesionSessile Serrated Lesion+1 more
Cold Water and Decision-Making
Started Aug 2025
40 enrolled
BehaviorStressQuality of Life+1 more
Worked on KIRSTY at Biocon? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.